BACTI_B: Proven infection prevention technology and strategic partnerships target a $80bn global market

About this update from Bactiguard Holding Ab

Antimicrobial resistance and healthcare-associated infections drive a large $80bn market opportunity. The company leverages proven infection prevention technology, focuses on licensing, and expands global partnerships, especially in wound management. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Bactiguard Holding Ab